Venus Remedies Closes Trading Window from Jan 1, 2026, pending Q3 FY26 results
Venus Remedies Limited (VRL) has announced the closure of its trading window for all designated persons. This closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015....
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Venus Remedies Limited in the news today?
Venus Remedies Limited (VENUSREM) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any information that would positively or negatively impact the company's performance or stock price.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Venus Remedies Closes Trading Window from Jan 1, 2026, pending Q3 FY26 results
December 23, 2025, 09:31 AM
Top Queries to Ask About Venus Remedies Limited
Venus Remedies Limited (VRL) has announced the closure of its trading window for all designated persons. This closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The trading window will be shut from January 1, 2026. It will remain closed until 48 hours after the declaration of the audited financial results for the period ending December 31, 2025.
Neha, Company Secretary, communicated this information on December 23, 2025.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
